1. Role of Androgen Receptors as a Prognostic and Predictive Biomarker in Triple-Negative Breast Cancer

   • Sameer Rastogi
   • Bhawna Sirohi

   Invited Commentary 30 September 2015 Pages: 171 - 174

2. The Cyclin D/Cyclin-dependent Kinase 4/6 Complex as a Target in the Treatment of Breast Cancer

   • Amy S. Clark
   • Angela DeMichele

   Clinical Trials (S Hurvitz, Section Editor) 26 August 2015 Pages: 175 - 182

   

3. Adjuvant Endocrine Therapy for Hormone Receptor-Positive Early Breast Cancer in Premenopausal Patient: Understanding the Data

   • Poornima Saha
   • Gini F. Fleming

   Clinical Trials (S Hurvitz, Section Editor) 14 September 2015 Pages: 183 - 189

   

4. Optimizing the Management of Metastatic HER2-Positive Breast Cancer

   • Shom Goel
   • Sara Tolaney

   Clinical Trials (S Hurvitz, Section Editor) 15 September 2015 Pages: 190 - 202

   

5. Targeting the Immune System in Breast Cancer: Hype or Hope?: TILs and Newer Immune-Based Therapies Being Evaluated for HER2+ and TNBC

   • Sibylle Loibl
   • Jenny Furlanetto

   Clinical Trials (S Hurvitz, Section Editor) 30 September 2015 Pages: 203 - 209

   

6. Clinical Implications of Mutations in the PI3K Pathway in HER2+ Breast Cancer: Prognostic or Predictive?

   • Ingrid A. Mayer

   Clinical Trials (S Hurvitz, Section Editor) 10 October 2015 Pages: 210 - 214

7. Potential Therapeutic Targets in Triple Negative Breast Cancer

   • Hamdy A. Azim
   • Hatem A. Azim Jr.

   Biomarkers (S Dawood, Section Editor) 23 September 2015 Pages: 215 - 223

   

8. Emerging Predictive Biomarkers of Response to Platinum Therapy in Triple-Negative Breast Cancer

   • Michal Mego
   • James M. Reuben

   Biomarkers (S Dawood, Section Editor) 01 October 2015 Pages: 224 - 231

9. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer

   • Koo Si-Lin
   • Loh Kiley
   • Yap Yoon Sim

   Biomarkers (S Dawood, Section Editor) 28 October 2015 Pages: 232 - 241